Cw-diamminedichloroplatinum(II) (cisplatin or cw-DDP) is a potent chemotherapeutic agent widely used in clinical practice against several types of human malignancies. The therapeutic ef fect is believed to arise as a consequence of cis-DD P binding to DNA (Sherman and Lippard, 1987), but it cannot be explained solely on the ba sis of DNA binding, because a number of closely related compounds, among which the geometric isomer trans-DDP, are not effective although they also damage DNA. The differential biological ef fect of different Pt-compounds may lie in the dif ferential processing of different Pt-DNA adducts by the cell. The realization that different adducts may be processed differently by the cell focused research on identifying proteins specifically in teracting with ds-DDP-modified DNA.
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ds-D D P and its biologically inactive stereo iso mer trans-D D P form different types of adducts upon interaction with DNA (Table I ). The main Other minor adducts may also arise, including interstrand cross-links involv ing guanine residues on opposite strands. The ther apeutically inactive /rani-DDP is incapable of forming the l,2d(G pG ) and d(ApG) adducts for stereochemical reasons, the two chloride ions be ing too far apart to be able to link neighbouring bases. It does form 1,3-intrastrand links and also cross-links opposite strands, but while ds-D D P re acts with guanine residues in d(GpC), the transisomer preferentially cross-links complementary G and C residues (see Table I ). Biochemical and structural studies on Pt-damaged DNA reveal ma jor distortions of the DNA double helix, including bending and unwinding (reviewed by Lilley, 1996) . Recent years have witnessed the discovery of a number of cellular proteins of still unidentified in vivo functions that recognize and bind selec tively to dsplatin-modified DNA. These include the chromatin nonhistone proteins H M G1 and H M G2, the human structure-specific recognition protein 1 (SS R P 1), the yeast intrastrand cross-link recognition protein lx rl, human UBF. All these proteins belong to the HMG 1-box protein family in that they contain one or multiple copies of a specific DNA-binding motif, the HMG 1-box, first described in the abundant HMG 2 proteins (Bustin and Reeves, 1996) . The HMG-1 box is known to 0 9 3 9 -5 0 7 5 /9 8 /0 1 0 0 -0 1 3 5 $ 06.00 © 1998 Verlag der Zeitschrift für Naturforschung. All rights reserved. N bind to distorted DNA structures and bend and unwind DNA upon binding (Grosscheid, 1995) .
Here we present evidence that another major chromatin protein, the linker histone H I, also binds preferentially to c/s-Pt-modified DNA.
Based upon a number of existing similarities in the binding of HMG1/2 and linker histones (H I, H 5, and subtypes) to DNA (Zlatanova and Yaneva, 1991; Zlatanova and van Holde, 1996) we hypothesized that these histones may also prefer entially bind to cz's-platinated DNA. In order to check this we performed band-shift experiments with globally platinated DNA fragments, obtained by restriction endonuclease digestions of plasmid DNAs. Such globally modified DNA fragments form a heterogenous population of molecules with different number of sites of modification.
To determine the correct ratio of DD P per nu cleotide needed to reach a saturation level of mod ification, plasmid p B R 322 codigested with restric tion endonuclease Hinc II/Eco RV, was titrated with increasing amounts of either the cis-or transisomer. The degree of modification was monitored by the retardation of the electrophoretic mobility of DNA, caused by the Pt-cross-linking (Fig. 1) . The retardation levelled off at about 0.025 DDP/ nucleotide, and this ratio was chosen for further experiments.
■ .... The first set of experiments on histone H 1 binding was performed with a Hinc II/Eco RV di gest of plasmid pBR 322. The population of re striction fragments was modified with either cisor frans-DDP; the unmodified digest was used as a control. The differently modified digests were titrated with increasing amounts of histone H 1 and analyzed by electrophoresis on polyacryl amide gels. Because the interaction of DNA with highly positively charged histone H I, the move ment of DNA fragments in the electrical field is retarded or fully stopped (in the cases of the for mation of insoluble protein/DNA complexes). The results (Fig. 2 A) demonstrate that a signifi cant decrease in the amount of unmodified DNA restriction fragments as a result of histone H I binding was first observed at one molecule of his tone H 1 per 32 bp of DNA. In contrast, much less histone H 1 was needed to obtain a similar degree of complex formation in case of both the cis-and the fra«s-modified fragments. The prefer ence of histone H 1 to c/s-modified DNA is espe cially well pronounced, since the first visible changes in the amount of soluble DNA fragments appear at 1 molecule of H 1 per 160 bp; the frag ments are completely complexed with the histone at one molecule of H 1 per 64 bp DNA. The for mation of insoluble complexes between the his tone and the DNA fragments was not unex pected, in view of the presence of two DNAbinding sites in the globular domain of the pro tein, which will facilitate the formation of net work aggregates (Ramakrishnan et al., 1993) .
When a Hinfl restriction digest of plasmid pUC19 was titrated with increasing amounts of histone H I, and then run on polyacrylamide gels, the electrophoretic patterns obtained with the modified and unmodified fragments again dif fered considerably (Fig. 2 B ) . With the unmodified control digest, the DNA fragments persisted in the gel even at the highest H1/DNA ratio tested, although the fragments were gradually shifted to higher positions in the gel, reflecting the binding of histone H 1 to DNA. The c/s-platinated frag ments, on the other hand, disappeared from the gel, forming insoluble H 1/DNA complexes, even at a ratio as small as one molecule of H I per 25 bp. The electrophoretic behaviour of the transmodified fragments was intermediate between that of unmodified and the c/s-platinated frag- ments, again, pointing out to a preference of bind ing of the histone to the ds-platinated DNA. The results obtained in this initial study show that histone H 1 binds preferentially to DNA frag ments modified with the therapeutically active ds-DDP. Further experiments will be needed to quantify the degree of preference and to try to understand whether it has some relevance to the biological activity of ds-DDP.
Experim ental
Bacterial plasmids p B R 322 and pU C19 were isolated and purified using standard procedures (Sambrock et al., 1989) . Digestions with restric tion endonucleases are performed following the recommendations of the manufacturer (New Eng land, BioLabs, U.S.A.). The purity of DNA prepa rations was checked on 1 % agarose gels.
For the modification of DNA fragments with platinum compounds DNA restriction fragments were incubated at 37 °C overnight with either cisor trans-DD P (see Table I ) in T E to various DDP/nucleotide molar ratios (Sherman and Lippard, 1987) . The isomers of DD P were synthe sized according to Spassovska et al., 1981. Dam aged DNA was freed from unbound D D P by ethanol precipitation.
